Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Non Operating Income (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Non Operating Income came in at -$95000.0 in Q1 2026, up 89.77% YoY from -$50059.6 in Q1 2025, and down 101.26% on a QoQ basis from $7.5 million in Q4 2025.

Abpro Holdings (ABPO) Non Operating Income (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Non Operating Income data on file, last reported at -$95000.0 in Q1 2026.

  • Quarterly Non Operating Income rose 89.77% year-over-year to -$95000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.4 million (up 464.33% YoY) and the FY2025 annual result came in at $5.6 million, up 106.77% from the prior year.
  • Non Operating Income eased to -$95000.0 in Q1 2026, from $7.5 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.5 million in Q4 2025 to a low of -$5.2 million in Q4 2023.
  • A 5-year average of $703254.1 and a median of -$95000.0 in 2026 frame the typical range for Non Operating Income.
  • The widest YoY moves for Non Operating Income: up 1435.64% in 2025, down 623.0% in 2025.
  • Tracing ABPO's Non Operating Income over 5 years: stood at $2.6 million in 2022, then tumbled by 300.1% to -$5.2 million in 2023, then soared by 89.06% to -$564000.0 in 2024, then jumped by 1435.64% to $7.5 million in 2025, then plunged by 101.26% to -$95000.0 in 2026.
  • The last three Non Operating Income figures came in at -$95000.0 (Q1 2026), $7.5 million (Q4 2025), and -$321000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -53.64 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -51.63 Mn
10 Abpro Holdings 1.14 Mn 1.14 Mn - 235,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -95,000.00
Dec 31, 2025 7.53 Mn
Sep 30, 2025 -321,000.00
Jun 30, 2025 -723,000.00
Mar 31, 2025 -929,000.00
Dec 31, 2024 -564,000.00
Sep 30, 2024 -162,000.00
Jun 30, 2024 -100,000.00
Mar 31, 2024 3.52 Mn
Dec 31, 2023 -5.16 Mn
Sep 30, 2023 366,622.00
Jun 30, 2023 1.54 Mn
Mar 31, 2023 3.29 Mn
Dec 31, 2022 2.58 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 243,932.00
Mar 31, 2022 -532,287.00